Advertisement
U.S. Markets closed

Celon Pharma S.A. (CLN.WA)

Warsaw - Warsaw Delayed Price. Currency in PLN
27.050.00 (0.00%)
At close: 05:00PM CET
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
171,539
164,394
161,915
169,559
135,480
Cost of Revenue
62,146
66,819
66,462
61,715
36,643
Gross Profit
109,393
97,575
95,453
107,844
98,837
Operating Expense
156,666
128,574
133,455
121,451
105,575
Operating Income
-47,273
-30,999
-38,002
-13,607
-6,738
Net Non Operating Interest Income Expense
-2,003
-1,725
-681
-2,039
-1,276
Pretax Income
-38,688
-19,968
-36,446
-15,087
-5,588
Tax Provision
6,793
8,156
2,831
-3,480
-4,671
Net Income Common Stockholders
-45,481
-28,124
-39,277
-11,607
-917
Diluted NI Available to Com Stockholders
-45,481
-28,124
-39,277
-11,607
-917
Basic EPS
-0.50
-0.55
-0.77
-0.25
-0.02
Diluted EPS
-0.50
-0.55
-0.77
-0.25
-0.02
Basic Average Shares
50,696
51,057
51,024
46,677
45,000
Diluted Average Shares
50,707
51,057
51,035
46,684
45,000
Total Operating Income as Reported
-43,745
-27,242
-37,336
-10,453
-3,673
Total Expenses
218,812
195,393
199,917
183,166
142,218
Net Income from Continuing & Discontinued Operation
-45,481
-28,124
-39,277
-11,607
-917
Normalized Income
-51,938
-38,204
-41,205
-11,709
-1,263
Interest Income
89
372
1,847
84
142
Interest Expense
2,505
2,662
1,671
1,553
667
Net Interest Income
-2,003
-1,725
-681
-2,039
-1,276
EBIT
-36,183
-17,306
-34,775
-13,534
-4,921
EBITDA
14,517
32,710
9,320
27,808
29,619
Reconciled Cost of Revenue
62,146
66,819
66,462
61,715
36,643
Reconciled Depreciation
50,700
50,016
44,095
41,342
31,767
Net Income from Continuing Operation Net Minority Interest
-45,481
-28,124
-39,277
-11,607
-917
Total Unusual Items Excluding Goodwill
7,971
10,080
1,928
132
427
Total Unusual Items
7,971
10,080
1,928
132
427
Normalized EBITDA
6,546
22,630
7,392
27,676
29,192
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,514
0
0
30.4474
81.13